Learn more

NAT CT NEUROLOGY & PSYCHIATRY

Overview
  • Total Patents
    27
  • GoodIP Patent Rank
    123,730
About

NAT CT NEUROLOGY & PSYCHIATRY has a total of 27 patent applications. Its first patent ever was published in 2011. It filed its patents most often in WIPO (World Intellectual Property Organization), China and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are MIRNA THERAPEUTICS INC, PRONAI THERAPEUTICS INC and NAT CENTER OF NEUROLOGY & PSYCHIATRY.

Patent filings in countries

World map showing NAT CT NEUROLOGY & PSYCHIATRYs patent filings in countries
# Country Total Patents
#1 WIPO (World Intellectual Property Organization) 22
#2 China 3
#3 United States 2

Patent filings per year

Chart showing NAT CT NEUROLOGY & PSYCHIATRYs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Yamamura Takashi 5
#2 Okada Takashi 5
#3 Takeda Shin Ichi 5
#4 Hohjoh Hirohiko 4
#5 Suzuki Yuko 3
#6 Ito Naoki 3
#7 Ruegg Urs 3
#8 Kohsaka Shinichi 3
#9 Hattori Kotaro 3
#10 Takeda Shinichi 3

Latest patents

Publication Filing date Title
WO2016117582A1 Marker for determining mental illness using mirna
WO2016114386A1 Therapeutic agent for progressive demyelinating immune disease
WO2016056645A1 Agent for inducing abnormal nucleic acid degradation
WO2016002827A1 Therapeutic agent for progressive demyelinating immune disease
WO2015174544A1 Mental illness determination marker
WO2015178288A1 Method for evaluating selective il-4 production inducing activity associated with nkt cell activation
WO2015125752A1 Cerebral circulatory disorder detection marker, cerebral circulatory disorder detection method using same, and cerebral circulatory disorder inhibitor
WO2015019979A1 Biomarker related to schizophrenia
WO2014200018A1 Method for predicting post-therapy prognosis of relapsing-remitting multiple sclerosis (rrms) patient, and method for determining applicability of novel therapy
WO2014119634A1 Muscle-building agent, and pharmaceutical composition containing same
WO2013147125A1 Drug intake enhancer
WO2013141202A1 Muscle-building agent and screening method for muscle-building substance
WO2013111746A1 Cognitive function testing system, cognitive function estimation system, cognitive function testing method, and cognitive function estimation method
WO2012147597A1 Camptocormia therapeutic agent
WO2013038740A1 Method for screening for substance or factor capable of promoting muscle hypertrophy
CN102753689A Marker for detection of myogenic diseases, and method for detection of the diseases using same